Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China

Chronic arsenic exposure via drinking water has become a worldwide public health concern. In humans, inorganic arsenic (iAs) is metabolized to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) mainly mediated by arsenic (+3 oxidation state) methyltransferase (As3MT). We reported recently that N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) was involved in arsenic metabolism, and examined its interactive effect with As3MT on arsenic metabolism in vitro. To further evaluate the interactive effect of N6AMT1 and As3MT on arsenic biomethylation in humans, we conducted a human population-based study including 289 subjects living in rural villages in Inner Mongolia, China, and assessed their urinary arsenic metabolites profiles in relation to genetic polymorphisms and haplotypes of N6AMT1 and As3MT. Five N6AMT1 single nucleotide polymorphisms (SNPs; rs1003671, rs7282257, rs2065266, rs2738966, rs2248501) and the N6AMT1 haplotype 2_GGCCAT were significantly associated with the percentage of iAs (% iAs) in urine (e.g., for rs7282257, mean was 9.62% for TT, 6.73% for AA). Rs1003671 was also in a significant relationship with urinary MMA and DMA (the mean of %MMA was 24.95% for GA, 31.69% for GG; the mean of % DMA was 69.21% for GA, 59.82% for GG). The combined effect of N6AMT1 haplotype 2_GGCCAT and As3MT haplotype 2_GCAC showed consistence with the additive significance of each haplotype on % iAs: the mean was 5.47% and 9.36% for carriers with both and null haplotypes, respectively. Overall, we showed that N6AMT1 genetic polymorphisms were associated with arsenic biomethylation in the Chinese population, and its interaction with As3MT was observed in specific haplotype combinations.

[1]  D. Aga,et al.  Interactive Effects of N6AMT1 and As3MT in Arsenic Biomethylation. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  E. Wieczorek,et al.  Biological monitoring and the influence of genetic polymorphism of As3MT and GSTs on distribution of urinary arsenic species in occupational exposure workers , 2014, International Archives of Occupational and Environmental Health.

[3]  Guifan Sun,et al.  Differences of Urinary Arsenic Metabolites and Methylation Capacity between Individuals with and without Skin Lesions in Inner Mongolia, Northern China , 2014, International journal of environmental research and public health.

[4]  C. Steinmaus,et al.  Occurrence of trivalent monomethyl arsenic and other urinary arsenic species in a highly exposed juvenile population in Bangladesh , 2014, Journal of Exposure Science and Environmental Epidemiology.

[5]  F. Harari,et al.  N-6-Adenine-Specific DNA Methyltransferase 1 (N6AMT1) Polymorphisms and Arsenic Methylation in Andean Women , 2013, Environmental health perspectives.

[6]  M. Bottai,et al.  Pregnancy and the methyltransferase genotype independently influence the arsenic methylation phenotype , 2012, Pharmacogenetics and genomics.

[7]  M. Gamble,et al.  Nutritional Manipulation of One-Carbon Metabolism: Effects on Arsenic Methylation and Toxicity , 2012, Journal of toxicology.

[8]  J. Qin,et al.  Identification of catalytic residues in the As(III) S-adenosylmethionine methyltransferase. , 2012, Biochemistry.

[9]  Baowei Chen,et al.  Mouse arsenic (+3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  P. Gómez-Rubio,et al.  Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. , 2011, Toxicology and applied pharmacology.

[11]  T. Agusa,et al.  Individual Variations in Inorganic Arsenic Metabolism Associated with AS3MT Genetic Polymorphisms , 2011, International journal of molecular sciences.

[12]  Robert S. Chen.  A Vast Machine: Computer Models, Climate Data, and the Politics of Global Warming , 2011 .

[13]  M. Valko,et al.  Arsenic: toxicity, oxidative stress and human disease , 2011, Journal of applied toxicology : JAT.

[14]  C. Vulpe,et al.  Involvement of N-6 Adenine-Specific DNA Methyltransferase 1 (N6AMT1) in Arsenic Biomethylation and Its Role in Arsenic-Induced Toxicity , 2010, Environmental health perspectives.

[15]  M. Vahter,et al.  Polymorphisms in Arsenic(+III Oxidation State) Methyltransferase (AS3MT) Predict Gene Expression of AS3MT as Well as Arsenic Metabolism , 2010, Environmental health perspectives.

[16]  Wei Yang,et al.  Prevalence of disability in an arsenic exposure area in Inner Mongolia, China. , 2010, Chemosphere.

[17]  P. Gómez-Rubio,et al.  Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10 , 2009, Journal of applied toxicology : JAT.

[18]  M. Vahter,et al.  Impact of Smoking and Chewing Tobacco on Arsenic-Induced Skin Lesions , 2009, Environmental health perspectives.

[19]  X Chris Le,et al.  Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. , 2009, Chemical research in toxicology.

[20]  Jeffrey C Barrett,et al.  Haploview: Visualization and analysis of SNP genotype data. , 2009, Cold Spring Harbor protocols.

[21]  L. D. Del Razo,et al.  Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. , 2009, Toxicology and applied pharmacology.

[22]  Y. Hsueh,et al.  Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer , 2009, Cancer Causes & Control.

[23]  M. Vahter,et al.  Arsenic metabolism is influenced by polymorphisms in genes involved in one-carbon metabolism and reduction reactions. , 2009, Mutation research.

[24]  S. Tanabe,et al.  Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam. , 2009, Toxicology and applied pharmacology.

[25]  C. Tseng.  A review on environmental factors regulating arsenic methylation in humans. , 2009, Toxicology and applied pharmacology.

[26]  T. Yasuda,et al.  DIVERSITY OF GLUTATHIONE S‐TRANSFERASE OMEGA 1 (A140D) AND 2 (N142D) GENE POLYMORPHISMS IN WORLDWIDE POPULATIONS , 2009, Clinical and experimental pharmacology & physiology.

[27]  G. Bowe,et al.  Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes. , 2008, Toxicology.

[28]  M. Vahter,et al.  The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. , 2008, Toxicology and applied pharmacology.

[29]  Yao Chen,et al.  Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects , 2007, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[30]  R. Kwok,et al.  Chronic Arsenic Exposure and Cardiac Repolarization Abnormalities with QT Interval Prolongation in a Population-based Study , 2007, Environmental health perspectives.

[31]  Xiance Sun,et al.  Urinary Arsenic Metabolites in Children and Adults Exposed to Arsenic in Drinking Water in Inner Mongolia, China , 2007, Environmental health perspectives.

[32]  M. Vahter,et al.  Genetic Polymorphisms Influencing Arsenic Metabolism: Evidence from Argentina , 2007, Environmental health perspectives.

[33]  S. Waters,et al.  Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals , 2007, Experimental biology and medicine.

[34]  T. Yoshimura,et al.  Arsenic in Drinking Water and Peripheral Nerve Conduction Velocity among Residents of a Chronically Arsenic-affected Area in Inner Mongolia , 2006, Journal of epidemiology.

[35]  M. Stýblo,et al.  shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. , 2006, Chemical research in toxicology.

[36]  Soile Tapio,et al.  Arsenic in the aetiology of cancer. , 2006, Mutation research.

[37]  Steve Selvin,et al.  Increased Mortality from Lung Cancer and Bronchiectasis in Young Adults after Exposure to Arsenic in Utero and in Early Childhood , 2006, Environmental health perspectives.

[38]  Eric D. Wieben,et al.  Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics , 2006, Journal of Biological Chemistry.

[39]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[40]  S. Waters,et al.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. , 2005, Toxicology and applied pharmacology.

[41]  F. Parvez,et al.  Folate, Homocysteine, and Arsenic Metabolism in Arsenic-Exposed Individuals in Bangladesh , 2005, Environmental health perspectives.

[42]  A. Blackburn,et al.  Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases , 2005, Pharmacogenetics and genomics.

[43]  S. Waters,et al.  Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. , 2005, Toxicology and applied pharmacology.

[44]  C. Tseng.  Blackfoot Disease and Arsenic: A Never-Ending Story , 2005, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[45]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[46]  S. Waters,et al.  Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. , 2004, Toxicology and applied pharmacology.

[47]  T. Yoshimura,et al.  Mental health burden amongst inhabitants of an arsenic-affected area in Inner Mongolia, China. , 2004, Social science & medicine.

[48]  H. Ahsan,et al.  Cancer burden from arsenic in drinking water in Bangladesh. , 2004, American journal of public health.

[49]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[50]  T. Yoshimura,et al.  The Prevalence of Subjective Symptoms after Exposure to Arsenic in Drinking Water in Inner Mongolia, China , 2003, Journal of epidemiology.

[51]  G. Sutherland,et al.  Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. , 2003, Pharmacogenetics.

[52]  D. Liebler,et al.  Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. , 2001, Chemical research in toxicology.

[53]  T. Yoshimura,et al.  Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China , 2001, Molecular and Cellular Biochemistry.

[54]  B. Fowler,et al.  Arsenic: health effects, mechanisms of actions, and research issues. , 1999, Environmental health perspectives.

[55]  A. Smith,et al.  Methylation study of a population environmentally exposed to arsenic in drinking water. , 1996, Environmental health perspectives.

[56]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[57]  W. Tseng,et al.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. , 1968, Journal of the National Cancer Institute.

[58]  Dianjun Sun,et al.  Urinary arsenic metabolism in a Western Chinese population exposed to high-dose inorganic arsenic in drinking water: influence of ethnicity and genetic polymorphisms. , 2014, Toxicology and applied pharmacology.

[59]  R. Marcos,et al.  Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. , 2008, Mutation research.

[60]  J. Harman.  Letter: Realistic goals for smoking and health. , 1974, Lancet.